Detalhe da pesquisa
1.
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?
Hum Mutat
; 41(1): 7-16, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553104
2.
Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples.
BMC Cancer
; 20(1): 366, 2020 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32357863
3.
Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories.
Br J Cancer
; 119(5): 605-614, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30140047
4.
What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases.
Hum Mutat
; 37(6): 570-5, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26920083
5.
RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres.
BMC Cancer
; 16(1): 825, 2016 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27784278
6.
External quality assessment unravels interlaboratory differences in quality of RAS testing for anti-EGFR therapy in colorectal cancer.
Oncologist
; 20(3): 257-62, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25657200
7.
Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect.
Virchows Arch
; 479(2): 365-376, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686511
8.
Describing the Reportable Range Is Important for Reliable Treatment Decisions: A Multiple Laboratory Study for Molecular Tumor Profiling Using Next-Generation Sequencing.
J Mol Diagn
; 20(6): 743-753, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30055348
9.
External Quality Assessment Identifies Training Needs to Determine the Neoplastic Cell Content for Biomarker Testing.
J Mol Diagn
; 20(4): 455-464, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625250
10.
A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer.
Oncotarget
; 9(29): 20524-20538, 2018 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755669
11.
The ins and outs of molecular pathology reporting.
Virchows Arch
; 471(2): 199-207, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28343306
12.
The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization.
PLoS One
; 9(11): e112159, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25386659